In a recent speech, President Biden overstated the average monthly cost that patients were paying prior to the Inflation Reduction Act: The out-of-pocket cost for insulin was $58 for a 30-day supply, says a HHS report.
President Biden's recent campaign statement is backed up by research, which has consistently found that U.S. Rx prices are significantly higher, sometimes 2-4 times as high, compared with prices in other countries.